13F-HR/A filed by SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC filed this 13F-HR/A for the quarter ended 2022-12-31, filed 2023-02-15, with 1 holding row worth $3,164,406.
- Accession
- 0001104659-23-022435
- Filer
- CIK 1744967
- Filed
- 2023-02-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, amendment of type new holdings, 1 entries on the cover page, a total value of $3,164,406 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,164,406 with VALUE read as dollars as filed, 13F file number 028-19375. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 881,450 | $3,164,406 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-021783 | base | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-23-022435 | this filing | 2023-02-15 | acceptance time not in the bulk data set |